Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLASMA: Varespladib in Stable Coronary Artery Disease
NCT00455546Phase 2Completed
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of varespladib in coronary artery disease (CAD), sponsored by Anthera Pharmaceuticals, Inc.. Started Apr 2007; status: completed.
02
Drugs
varespladib
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00455546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455546.